Liver dysfunction in allogeneic bone marrow transplantation recipients: Influence of pre- and posttransplantation hepatic lesions

Transplantation

Volumn 62, Issue 1, 1996, Pages 56-61

  Azar, Nabih ^a   Valla, Dominique ^a   Abdel Samad, Issam ^a   Hoang, Catherine ^a   Fretz, Catherine ^a   Sutton, Laurent ^a   Fournel, Jean Jacques ^a   Le Charpentier, Yves ^a   Binet, Jacques Louis ^a   Leblond, Véronique ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION; MALE; PRIORITY JOURNAL; RECIPIENT; SIDEROSIS; VIRUS HEPATITIS;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BIOPSY, NEEDLE; BONE MARROW TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES; TIME FACTORS;

EID: 8944242607     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00012     Document Type: Article

References (30)

1. McDonald GB, Shulman HM, Wolford JL, Spencer GD. Liver disease after human marrow transplantation. Semin Liver Dis 1987; 7: 210.
2. Snover DC, Weisdorf SA, Ramsay NK, McGlave P, Kersey JH. Hepatic graft-versus-host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology 1984; 4: 123.
3. Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB. A coded histological study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology 1988; 8: 463.
4. Shulman HM, Hinter-Berger W. Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197.
5. Ganem G, Saint-Marc Girardin MF, Kuentz M. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988; 14: 879.
6. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005.
7. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multi-organ failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255.
8. McDonald GB, Sharma P, Matthews DE, et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116.
9. Brugieres L, Hartmann O, Benhamou E, et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3: 53.
10. Jones RJ, Lee KSK, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778.
11. Loscasciulli A, Alberti A, De Bock R, et al. The impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the EBMT-infections disease working party. Bone Marrow Transplant 1994; 14: 833.
12. Carreras E, Granena A, Narvasa M, et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993; 11: 21.
13. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729.
14. Shulman HM, McDonald GB, Matthews D, et al. An analysis of hepatic veno-occlusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980; 79: 1178.
15. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295.
16. Gerlich WH, Thomsen R. Terminology, structure, and laboratory diagnosis of hepatitis viruses. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford UP, 1991: 537.
17. Gerber MA. Pathology of acute and chronic viral hepatitis. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford UP, 1991: 530.
18. Kodama T, Tamaki T, Katabami S, et al. Histological findings in asymptomatic hepatitis C virus carriers. J Gastroenterol Hepatol 1993; 8: 403.
19. Anderson KC, Weinstein HJ. Transfusion associated graft-versus-host disease. N Engl J Med 1990; 323: 315.
20. Bertheaux P, Cazals-Hatem D, Hadengue A, et al. Cholestasis after allogeneic bone marrow transplantation: clinical versus pathological correlation [Abstract]. Gastroenterology 1993; 104: A877.
21. Ozkaynak MF, Weinberg K, Kohn D, et al. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, clinical outcome. Bone Marrow Transplant 1991; 7: 467.
22. Dulley FL, Kanfer EJ, Appelbaum FR, et al. Veno-occlusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43: 870.
23. Blostein MD, Paltiel OB, Thibault A, et al. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 439.
24. Cross CE, Halliwell B, Borish ET, et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526.
25. Jones A, Selby PJ, Viner C, et al. Tumor necrosis factor, cholestatic jaundice, and chronic liver disease. Gut 1990; 31: 938.
26. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457.
27. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachexin. Lab Invest 1991; 64: 724.
28. Symington FW, Symington BE, Liu PY, et al. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation 1992; 54: 457.
29. Ferrera JLM. Cytokine dysregulation as a mechanism of graft-versus-host disease. Curr Opin Immunol 1993; 5: 794.
30. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor precede major complications of bone marrow transplantation. Blood 1990; 75: 1011.